Prostaglandin Analogues – Draft SCCS Opinion

Prostaglandin Analogues – Draft SCCS Opinion

Summary: Substance: Prostaglandin AnaloguesEffected Products: Eyelash and eyebrow growth productsDate of Implementation: Unapplicable, SCCS Opinion stage On 6 June 2025, the Scientific Committee on Consumer Safety (SCCS) released its draft opinion concerning...
New SCCS Mandate for Prostaglandin Analogues

New SCCS Mandate for Prostaglandin Analogues

On 27 March 2024, the Scientific Committee on Consumer Safety (SCCS) adopted a new mandate to review the safety of prostaglandin analogues (ethyl tafluprostamide – DDDE, methylamido-dihydro-noralfaprostal – MDN, and isopropyl cloprostenate – IPCP) in...